Chang, Xuling
Dorajoo, Rajkumar
Sun, Ye
Han, Yi
Wang, Ling
Khor, Chiea-Chuen
Sim, Xueling
Tai, E-Shyong
Liu, Jianjun
Yuan, Jian-Min
Koh, Woon-Puay
van Dam, Rob M.
Friedlander, Yechiel
Heng, Chew-Kiat
Funding for this research was provided by:
National Institute of Health, USA (R01 CA144034 and UM1 CA182876)
National Institute of Health, USA (R01 CA144034 and UM1 CA182876)
National Medical Research Council (NMRC) and the Biomedical Research Council
National Medical Research Council (NMRC) and the Biomedical Research Council
HUJ-CREATE Programme of the National Research Foundation, Singapore (370062002)
HUJ-CREATE Programme of the National Research Foundation, Singapore (370062002)
Article History
Received: 30 November 2017
Accepted: 14 February 2018
First Online: 24 February 2018
Ethics approval and consent to participate
: The Singapore Chinese Health Study (SCHS) was approved by the Institutional Review Boards (IRB) of the National University of Singapore (NUS) and the University of Minnesota (UMN), and all study subjects gave written informed consent.The Singapore Prospective Study Program (SP2) was approved by the IRB of NUS and the Singapore General Hospital. All participants gave informed written consent before the study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.